EichorEICHOR
Study identifier: NCT07464808 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Recruiting

Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management

Condition: Venous Thromboembolic Event  ·  Sponsor: Ain Shams University

PhaseNA
Planned participants25
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients

This description comes directly from the study's public registry record.

Talk to the study team

Doaa Ahmed Diaa El din Ibrahim, MD  ·  01128904628  ·  Doaaeldin@med.asu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Ain Shams UniversityCairo, Abbassia, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →